BackPURE Bioscience Overview

PURE Bioscience Receivables

Track PURE Bioscience's receivables ($240K) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Receivables
$242000.00
↓ 15.68% YoYΔ $-45000.00 vs prior year quarter

Peer trimmed avg / median

Loading

PURE Bioscience Receivables History

Loading

PURE Bioscience vs. peers: Receivables Comparison

Loading

PURE Bioscience Receivables Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

PURE Bioscience (PURE) FAQ

PURE Bioscience (PURE) currently reports a receivables of $240K as of April 2026. That compares with $290K in the prior-year period — down 15.7% year over year. Use the charts on this page to explore PURE Bioscience's receivables history and peer comparisons.

PURE Bioscience's receivables decreased from $290K to $240K — a 15.7% year-over-year decrease (period ending April 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

PURE Bioscience reported $240K in receivables as of April 2026. That compares with $290K in the prior-year period — down 15.7% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current receivables of $240K, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for PURE Bioscience, and consider following PURE for alerts when major investors trade the stock.